Market revenue in 2020 | USD 2,671.9 million |
Market revenue in 2028 | USD 4,621.6 million |
Growth rate | 7.1% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments, Software & Services |
Key market players worldwide | Diasorin SpA, Abbott Laboratories, Siemens Healthineers AG ADR, QuidelOrtho Corp, shenzhen mindray automation equipment co., Immunodiagnostic Systems, Beckman Coulter, Roche Holding AG ADR, Roche, Inova Diagnostics, Maccura |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to chemiluminescence immunoassay market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 65.57% in 2020. Horizon Databook has segmented the U.S. chemiluminescence immunoassay market based on consumables, instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
The growth in this region can mainly be attributed to high adoption of technologically advanced CLIA products, favorable reimbursement scenario, and increase in the prevalence of chronic & infectious diseases.
According to CDC estimates, in 2018, around 37,377 new cases of HIV were diagnosed in the U.S. The data from the same source states that 115,045 new cases of syphilis were recorded in 2018. Moreover, according to American Cancer Society, in 2020, an estimated 1.8 million new cases of cancer were diagnosed in the U.S.
In addition, local presence of leading players in the U.S. and continuous strategic initiatives undertaken by them are anticipated to fuel the market growth. For instance, in October 2020, DiaSorin, an Italy-based CLIA manufacturer, received FDA’s EUA for its new LIAISON SARS-CoV-2 IgM test.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. chemiluminescence immunoassay market , including forecasts for subscribers. This country databook contains high-level insights into U.S. chemiluminescence immunoassay market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account